Commentary

Podcast

Pharmacy Focus: Psychedelic Pharmacy- Investigating Psilocybin-Assisted Therapy

Jordan Sloshower, MD, MSc, describes his experience working in several clinical trials investigating psilocybin-assisted therapy.

This month, we spoke with Jordan Sloshower, MD, MSc, about an upcoming course titled Critical Perspectives on Knowledge Production in Psychedelic Science at Chacruna Institute in which he will be addressing some issues regarding psilocybin-assisted therapy.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Related Content
FDA website -- Image credit: Postmodern Studio | stock.adobe.com
September 4th 2025

FDA Approves Ketamine for Surgical Pain Management

Gillian McGovern, Associate Editor
Pharmacy Focus Oncology Edition Podcast
September 4th 2025

Protecting Community Oncology Practices in the Wake of the IRA

Alexandra Gerlach, Associate Editor
Health care professional prepping psilocybin -- Image credit: Microgen | stock.adobe.com
September 4th 2025

Investigating the Pharmacist’s Role in Psychedelic-Assisted Psychotherapy for Patients With Cancer

Andrew Whitman, PharmD, BCOP
From Guidelines to Action: Pharmacy’s Role in Hypertension Management
September 4th 2025

From Guidelines to Action: Pharmacy’s Role in Hypertension Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Psilocybin at the Crossroads: Regulatory Barriers and the Pharmacist’s Role in Palliative Innovation
September 4th 2025

Psilocybin at the Crossroads: Regulatory Barriers and the Pharmacist’s Role in Palliative Innovation

Abigail Thomas, PharmD Lee A. Kral, PharmD Alana Hippensteele, Lead Editor
Emerging Efforts to Expand Access to Psilocybin Therapy: A Critical Opportunity for Underserved Communities Facing Mental Health and Addiction Crises
September 4th 2025

Emerging Efforts to Expand Access to Psilocybin Therapy: A Critical Opportunity for Underserved Communities Facing Mental Health and Addiction Crises

Alana Hippensteele, Lead Editor
© 2025 MJH Life Sciences

All rights reserved.